Medscape reports early clinical trial work on weight-loss therapies designed for once- or twice-yearly dosing, suggesting a potential adherence and delivery shift if efficacy and safety hold up.
Weight-loss treatment may soon require far fewer injections—but it’s still early.
therapies designed to be given just once or twice a year, with early results suggesting meaningful, sustained weight loss.
researchers are studying therapies designed to be given just once or twice a year, with early results suggesting meaningful, sustained weight loss.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare